Article Versions Notes

Primorac D, Čemerin M, Matišić V, Molnar V, Strbad M, Girandon L, Zenić L, Knežević M, Minger S, Polančec D. Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment. Pharmaceutics. 2021; 13(9):1481. https://doi.org/10.3390/pharmaceutics13091481

Primorac, Dragan, Martin Čemerin, Vid Matišić, Vilim Molnar, Marko Strbad, Lenart Girandon, Lucija Zenić, Miomir Knežević, Stephen Minger, and Denis Polančec. 2021. "Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment" Pharmaceutics 13, no. 9: 1481. https://doi.org/10.3390/pharmaceutics13091481

Primorac, D., Čemerin, M., Matišić, V., Molnar, V., Strbad, M., Girandon, L., Zenić, L., Knežević, M., Minger, S., & Polančec, D. (2021). Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment. Pharmaceutics, 13(9), 1481. https://doi.org/10.3390/pharmaceutics13091481